0000905718-21-001237.txt : 20210928
0000905718-21-001237.hdr.sgml : 20210928
20210928130816
ACCESSION NUMBER: 0000905718-21-001237
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210928
DATE AS OF CHANGE: 20210928
EFFECTIVENESS DATE: 20210928
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cingulate Inc.
CENTRAL INDEX KEY: 0001862150
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863825535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-414866
FILM NUMBER: 211285611
BUSINESS ADDRESS:
STREET 1: 1901 W. 47TH PLACE
CITY: KANSAS CITY
STATE: KS
ZIP: 66205
BUSINESS PHONE: (913) 942-2300
MAIL ADDRESS:
STREET 1: 1901 W. 47TH PLACE
CITY: KANSAS CITY
STATE: KS
ZIP: 66205
D
1
primary_doc.xml
X0708
D
LIVE
0001862150
Cingulate Inc.
1901 W. 47TH PLACE
KANSAS CITY
KS
KANSAS
66205
(913) 942-2300
DELAWARE
None
None
Corporation
true
2021
Gregg
Givens
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Curt
Medeiros
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Shane
J
Schaffer
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Executive Officer
Director
Patrick
Gallagher
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Jeff
Hargroves
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Peter
J
Werth
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Jeff
Conroy
1901 W. 47th Place
Kansas City
KS
KANSAS
66205
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
true
false
true
true
0
220000000
0
220000000
Implied per share value. Stock exchange in connection with restructuring merger.
true
0
0
0
0
false
Cingulate Inc.
/s/ Craig S. Gilagallon
Craig S. Gilgallon
General Counsel
2021-09-28